ISRG241018C500000
- 7.40
- +0.60+8.82%
Intuitive Surgical Newsroom
Intuitive Surgical Analyst Ratings
Truist Financial Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $570
Raymond James Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $540
Intuitive Surgical Is Maintained at Buy by Truist Securities
BTIG Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $518
Intuitive Surgical (ISRG) Receives a Hold From Deutsche Bank
J.P. Morgan Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $575
Intuitive Surgical Analyst Ratings
RBC Capital Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $525
BTIG Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $494
Buy Rating on Intuitive Surgical: Expanding Robotic Surgery Into Emergency Procedures Promises Market Growth
Intuitive Surgical Is Maintained at In-Line by Evercore ISI Group
Intuitive Surgical Analyst Ratings
Evercore ISI Adjusts Intuitive Surgical Price Target to $475 From $410
BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $550
BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $550
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (ISRG), HCA Healthcare (HCA) and Teleflex (TFX)
BTIG Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $494
Intuitive Surgical Analyst Ratings
BTIG Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $494